跳至主要内容
临床试验/ACTRN12611001051932
ACTRN12611001051932已完成未知

Termination of early pregnancy using mifepristone 200mg followed by buccal administration of misoprostol 800mcg – retrospective review of efficacy and safety – Australian Authorised Prescriber Program.

Marie Stopes International Australia0 个研究点目标入组 13,000 人开始时间: 2011年10月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
13,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
14 Years 至 50 Years(—)
性别
Female

入选标准

  • Confirmed pregnancy up to 9 weeks gestation.
  • Informed consent.
  • No contraindications.
  • Must meet legal requirements for termination of pregnancy in the state where the service is provided.

排除标准

  • More than 9 weeks since the last menstrual period (confirmed by ultrasound).
  • Known or suspected ectopic pregnancy.
  • Concomitant administration of anticoagulants or corticosteroids.
  • Adrenal failure, inherited porphyria or a haemorrhagic disorder.
  • Allergy to mifepristone or misoprostol.
  • Intrauterine device insitu
  • Pelvic infection

研究者

相似试验